Hereditary Angioedema Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Hereditary Angioedema Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : August, 2021 | Pharmaceutical

Report Digest


Global Hereditary Angioedema Market: An Overview

Hereditary angioedema develops in the most common areas of the body and results in recurrent episodes of severe swelling. The condition affects intestinal tract, limbs, and airways. Moreover, episodes of trauma, can trigger an attack, but the probable cause of these are still yet unconfirmed. The condition results in fatalities for one-third of the people, and can progress into a rash called arythema marginatum during an attack. There are three types of hereditary angioedema. Among these, type I is the most common condition, and affects over 85% of patients, while type II affects nearly 15%. Type III is most rare among them all. The condition affects over 1 in 50,000 people, and its growing awareness is expected to drive growth for players in the hereditary angioedema market. Recent technological advancements including Big Data, and data analysis are expected to open new opportunities for growth in the hereditary angioedema market in the near future.

Global Hereditary Angioedema Market: Notable Developments

BioCryst Pharmaceuticals has submitted a new drug application to the FDA for approval of Berotralstat. The oral and daily dose of this medicine has been tested and promises to prevent swelling attacks in patients for a year. The drug highly needed for the hereditary angioedema condition has shown promising results in ApeX-2, and Apex-S trials that it is safe and effective while lowering mean attack rates from three to one or fewer per month.

Growing awareness about genetic mutations, and initiative for protecting new-borns against genetic illnesses are expected to result in further regulatory support in the US. Currently, legislation in senate named the Newborn Screeing Saves Lives Reauthorization, promises awaits senate vote. If passed, the bill will provide $60 million yearly funding to states to enact newborn screening programs. The new programs with the help of the National Academy of Medicine, will drive growth of implementation, and make recommendation for new ones. Currently, the yearly funding stands at $20 million a year. The rising awareness about genetic illnesses, and growing support in the senate will likely drive growth for players in the hereditary angioedema market.

Global Hereditary Angioedema Market: Drivers and Restraints

The global hereditary angioedema market is likely to witness major growth as rising genetic screening, and technological advancements like Big Data continue to result in better diagnosis, and more treatment. Moreover, growing support for regulatory bodies like the FDA for rare conditions, and legislations like Newborn Screening Saves Lives Reauthorization also promise new opportunities for expansions in key markets. Moreover, various pharmaceutical companies are investing in innovation as expiry of various patents, increased regulatory support for innovation, and reducing costs for innovations due to outsourcing of various operations continues to drive growth for players in the hereditary angioedema market.

Global Hereditary Angioedema Market: Geographical Outlook

The global hereditary angioedema market report will cover all key regions of the globe including North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Among these, North America and Europe are likely to witness major growth, thanks to new drug approvals, growing investment in innovation, and promising horizons of drug development with technological advancements like 3D printing among others. The global hereditary angioedema market in Asia pacific will also witness substantial growth as countries like China, and the promising push of the Chinese FDA for innovation promises new opportunities for regional players. Moreover, expanding access to healthcare, promising innovation in countries like India, and Japan, and rising disposable income are likely to drive new opportunities for growth in the hereditary angioedema market during the forecast period.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

  • What are the diverse growth parameters influencing the market?
  • Which regions will contribute largely to the growth of the market
  • What are the recent innovations and technological advancements in the market?
  • What are the emerging trends across the market?
  • How has COVID-19 affected the market?
  • What will be the post-pandemic scenario of the market?
  • What are the major threats that will dent the growth prospects of the market?